CDI Treatment Evolution: Antibiotics, Biotherapeutics, and Vaccines Shaping the Future
A Decade of Change in Clostridioides difficile Management For years, the primary approach to managing Clostridioides difficile infections (CDI) relied on vancomycin and metronidazole (Flagyl). Limitations such as recurrence and emerging resistance became increasingly apparent. The introduction of fidaxomicin (Dificid) offered a more targeted therapy, sparking clinical comparisons like Zinplava...
0 Комментарии 0 Поделились 535 Просмотры 0 предпросмотр
Спонсоры
Спонсоры
Спонсоры
Спонсоры